Mosaic Hemagglutinin-Based Influenza B mRNA-LNP Vaccine Induces Strong Humoral Immune Response in Non-Human Primates.
Developing broadly protective influenza vaccines remains a major challenge for global public health. Influenza B viruses cause about one-third of all annual influenza virus infections and current vaccines only show moderate effectiveness against matched virus strains, therefore, development of more effective and broadl...